Ignite Creation Date:
2025-12-25 @ 1:22 AM
Ignite Modification Date:
2026-03-22 @ 6:49 PM
Study NCT ID:
NCT01597193
Status:
COMPLETED
Last Update Posted:
2019-05-08
First Post:
2012-05-09
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Safety Study of Enzalutamide (MDV3100) in Patients With Incurable Breast Cancer
Sponsor:
Pfizer
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
MDV3100-08
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None